1023 related articles for article (PubMed ID: 16750463)
21. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
Aurora SK; Rozen TD; Kori SH; Shrewsbury SB
Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
[TBL] [Abstract][Full Text] [Related]
22. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths.
Cutler N; Mushet GR; Davis R; Clements B; Whitcher L
Neurology; 1995 Aug; 45(8 Suppl 7):S5-9. PubMed ID: 7644082
[TBL] [Abstract][Full Text] [Related]
23. Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea.
Schulman EA
Headache; 2012 Feb; 52(2):204-12. PubMed ID: 22229837
[TBL] [Abstract][Full Text] [Related]
24. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J
Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717
[TBL] [Abstract][Full Text] [Related]
25. Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial.
Silberstein SD; Freitag FG; Rozen TD; Kudrow DB; Hewitt DJ; Jordan DM; Fisher AC; Rosenthal NR;
Headache; 2005; 45(10):1317-27. PubMed ID: 16324164
[TBL] [Abstract][Full Text] [Related]
26. [Sumatriptan treatment of migraine in general practice. A randomized, double-blind, placebo-controlled cross-over study].
Russell MB; Holm-Thomsen OE; Nielsen MR; Cleal A; Pilgrim AJ; Olesen J
Ugeskr Laeger; 1995 Apr; 157(16):2320-3. PubMed ID: 7652970
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
[TBL] [Abstract][Full Text] [Related]
28. Oral sumatriptan for the long-term treatment of migraine: clinical findings.
Rederich G; Rapoport A; Cutler N; Hazelrigg R; Jamerson B
Neurology; 1995 Aug; 45(8 Suppl 7):S15-20. PubMed ID: 7644080
[TBL] [Abstract][Full Text] [Related]
29. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
30. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
Gawel M; Aschoff J; May A; Charlesworth BR;
Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
32. Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial.
Thomson AN; Arthur GP; Bergin PS; Pollock M; Parkin PJ; Flanagan M; Samson SA
N Z Med J; 1993 May; 106(955):171-3. PubMed ID: 8389026
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
[TBL] [Abstract][Full Text] [Related]
34. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks.
Diener HC; Bussone G; de Liano H; Eikermann A; Englert R; Floeter T; Gallai V; Göbel H; Hartung E; Jimenez MD; Lange R; Manzoni GC; Mueller-Schwefe G; Nappi G; Pinessi L; Prat J; Puca FM; Titus F; Voelker M;
Cephalalgia; 2004 Nov; 24(11):947-54. PubMed ID: 15482357
[TBL] [Abstract][Full Text] [Related]
35. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies.
Silberstein SD; Armellino JJ; Hoffman HD; Battikha JP; Hamelsky SW; Stewart WF; Lipton RB
Clin Ther; 1999 Mar; 21(3):475-91. PubMed ID: 10321417
[TBL] [Abstract][Full Text] [Related]
36. Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial.
Alemdar M; Pekdemir M; Selekler HM
Clin Ther; 2007 Jul; 29(7):1441-7. PubMed ID: 17825695
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group.
Pini LA; Fabbri L; Cavazzuti L
Int J Clin Pharmacol Res; 1999; 19(2):57-64. PubMed ID: 10669900
[TBL] [Abstract][Full Text] [Related]
38. Intranasal sumatriptan powder delivered by a novel breath-actuated bi-directional device for the acute treatment of migraine: A randomised, placebo-controlled study.
Djupesland PG; Docekal P;
Cephalalgia; 2010 Aug; 30(8):933-42. PubMed ID: 20656704
[TBL] [Abstract][Full Text] [Related]
39. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
[TBL] [Abstract][Full Text] [Related]
40. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
